Header Logo

Connection

CHRIS AMOS to Abiraterone Acetate

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Abiraterone Acetate.
CHRIS AMOS
Connection Strength
0.147
Abiraterone Acetate
  1. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol. Ann Oncol. 2018 05 01; 29(5):1235-1248.
    View in: PubMed
    Score: 0.147
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.